Literature DB >> 12063020

Monoclonal antibody 9C4 recognizes epithelial cellular adhesion molecule, a cell surface antigen expressed in early steps of erythropoiesis.

Reiner Lammers1, Christina Giesert, Frank Grünebach, Anke Marxer, Wichard Vogel, Hans Jörg Bühring.   

Abstract

OBJECTIVE: Monoclonal antibody (mAb) 9C4 detects a surface antigen expressed on immature erythroid progenitor cells and epithelial tumor cell lines. The aim of this study was to identify the recognized surface antigen and to analyze a potential role of this molecule in early steps of erythropoiesis.
MATERIALS AND METHODS: A pituitary-derived retroviral cDNA library was used to generate viruses and infect NIH-3T3 fibroblasts. The transfected cells were stained with mAb 9C4; positive cells were sorted by FACS; and a clonal cell line binding mAb 9C4 was established. cDNA encoding the 9C4-binding protein was amplified by polymerase chain reaction and cloned. Reactivity of mAb 9C4 with human bone marrow (BM) cells was analyzed by flow cytometry.
RESULTS: Sequence analysis of the isolated cDNA uncovered a 100% identity with the epithelial cellular adhesion molecule (Ep-CAM). Two-color flow cytometric analysis revealed that almost 100% of Ep-CAM(+) BM cells coexpressed CD105, E-cadherin, and high levels of CD71. Fractions of Ep-CAM(+) BM cells also were CD34(+) but lacked glycophorin A expression, suggesting that Ep-CAM(+) cells represent immature erythroid cells. Reverse transcriptase polymerase chain reaction analysis of BM mononuclear cells revealed that the 9C4(+) erythroblast population but not the 9C4(-) fraction expressed Ep-CAM mRNA. Peripheral blood CD34(+) cells induced in vitro to differentiate into the erythroid lineage showed strong Ep-CAM expression on days 3 to 7 of culture. The addition of Ep-CAM-specific mAbs 9C4 or KS1/4 to the culture resulted in two- to three-fold up-regulation of Ep-CAM protein expression.
CONCLUSION: mAb 9C4 recognizes Ep-CAM, a molecule expressed in the early steps of erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12063020     DOI: 10.1016/s0301-472x(02)00798-1

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  16 in total

1.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

2.  Prospective isolation of human erythroid lineage-committed progenitors.

Authors:  Yasuo Mori; James Y Chen; John V Pluvinage; Jun Seita; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-20       Impact factor: 11.205

Review 3.  Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies.

Authors:  Emma E van der Toom; Haley D Axelrod; Jean J de la Rosette; Theo M de Reijke; Kenneth J Pienta; Kenneth C Valkenburg
Journal:  Nat Rev Urol       Date:  2019-01       Impact factor: 14.432

Review 4.  The biology and clinical implications of prostate cancer dormancy and metastasis.

Authors:  Colm Morrissey; Robert L Vessella; Paul H Lange; Hung-Ming Lam
Journal:  J Mol Med (Berl)       Date:  2015-10-21       Impact factor: 4.599

5.  The human placenta is a hematopoietic organ during the embryonic and fetal periods of development.

Authors:  Alicia Bárcena; Mirhan Kapidzic; Marcus O Muench; Matthew Gormley; Marvin A Scott; Jingly F Weier; Christy Ferlatte; Susan J Fisher
Journal:  Dev Biol       Date:  2008-12-03       Impact factor: 3.582

6.  Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.

Authors:  C Milsmann; L Füzesi; E Heinmöller; P Krause; C Werner; H Becker; O Horstmann
Journal:  Langenbecks Arch Surg       Date:  2007-09-18       Impact factor: 3.445

7.  Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence.

Authors:  Todd M Morgan; Paul H Lange; Michael P Porter; Daniel W Lin; William J Ellis; Ian S Gallaher; Robert L Vessella
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

8.  Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients.

Authors:  Mark A Watson; Lourdes R Ylagan; Kathryn M Trinkaus; William E Gillanders; Michael J Naughton; Katherine N Weilbaecher; Timothy P Fleming; Rebecca L Aft
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

9.  A new role for the human placenta as a hematopoietic site throughout gestation.

Authors:  Alicia Bárcena; Marcus O Muench; Mirhan Kapidzic; Susan J Fisher
Journal:  Reprod Sci       Date:  2009-02       Impact factor: 3.060

10.  Prostate Cancer Disseminated Tumor Cells are Rarely Detected in the Bone Marrow of Patients with Localized Disease Undergoing Radical Prostatectomy across Multiple Rare Cell Detection Platforms.

Authors:  Heather J Chalfin; Stephanie A Glavaris; Paymaneh D Malihi; Jamie M Sperger; Michael A Gorin; Changxue Lu; C Rory Goodwin; Yan Chen; Emily A Caruso; Ruth Dumpit; Peter Kuhn; Joshua M Lang; Peter S Nelson; Jun Luo; Kenneth J Pienta
Journal:  J Urol       Date:  2018-01-12       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.